MedTech Business - January 23, 2017
Bone Index receives FDA clearance
Bone Index has received 510(k) clearance from the Food and Drug Administration (FDA) for the second generation Bindex point-of-care device model to help in osteoporosis diagnosis. Bindex measures the cortical bone thickness of the tibia and the algorithm calculates the Density Index, a parameter which estimates bone mineral density at the hip as measured with […]
Uncategorized - May 12, 2015
Portable Device IDs Osteoporosis
Bindex, a pocket-sized diagnostic device for osteoporosis developed by the Kuopio medical device manufacturer Bone Index, shows measurement accuracy that meets international requirements, according to a recent medical study, and it could be recommended for use in primary health care offices. The results of a large international study were published at the World Congress on […]
